Subscribe

US Drugmakers Leave NHS Pricing Agreement as Costs Increase

  • AbbVie and Eli Lilly have withdrawn from the NHS pricing agreement.
  • This is due to the levy on branded drugs reaching a quarter of UK sales.
  • The costs of the drugs have increased.
0
0
Share 0
Tweet 0
Share 0
Total
0
Shares
5/5
Via
Join 2 million subscribers





  • Location

subscribe to the nextbigwhat newsletter​

A curated newsletter that summarizes the important news at the intersection of Global tech, India Tech and AI.

Delivered 8 AM. Daily.

More news »

Total
0
Share
0
0
0
0
0
0